Medicare Enrolled

Dr. Valeriu Neagu, M.D.

Internal Medicine · Naples, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
1019 CROSSPOINTE DR STE 1, Naples, FL 34110
2397996950
Registered in NPPES since 2009
NPI: 1306089156 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Neagu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neagu? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Neagu

Dr. Valeriu Neagu is an internal medicine specialist in Naples, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Neagu performed 5,685 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Neagu received a total of $90,892 from 58 pharmaceutical and/or device companies across 446 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Neagu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 7% volume in FL $90,892 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 137956 Clear January 31, 2027 —
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
5,685
Medicare services
Top 7% in FL for internal medicine
Not available
Unique patients (not deduplicated)
$33
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 4,020 $17 $48
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
958 $93 $234
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
153 $8 $17
Continuous glucose monitoring with interpretation
This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results.
150 $26 $78
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
142 $126 $332
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
122 $10 $38
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
77 $8 $45
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
26 $108 $313
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
24 $54 $158
New patient office visit, complex (60-74 min) 13 $163 $429
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$90,892
Total received (2018-2024)
Avg $12,985/year across 7 years
Top 1% in FL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
446
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,161
2023
$5,897
2022
$21,367
2021
$10,163
2020
$7,085
2019
$1,455
2018
$41,763

Payments by company (2024)

Takeda Pharmaceuticals U.S.A., Inc.
$381
GENZYME CORPORATION
$305
Radius Health, Inc.
$195
CSL Behring
$173
Novo Nordisk Inc
$164
Xeris Pharmaceuticals, Inc.
$161
Dexcom, Inc.
$159
Lilly USA, LLC
$149
AstraZeneca Pharmaceuticals LP
$141
Corcept Therapeutics
$131
Almatica Pharma LLC
$111
Alexion Pharmaceuticals, Inc.
$83
IBSA Pharma Inc.
$81
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
Antares Pharma, Inc.
$78
BETA BIONICS, INC.
$71
Insulet Corporation
$62
Abbott Laboratories
$61
Esperion Therapeutics, Inc.
$53
Genentech USA, Inc.
$46
SANOFI-AVENTIS U.S. LLC
$43
ABBVIE INC.
$42
Amgen Inc.
$38
Tandem Diabetes Care, Inc.
$38
Amneal Pharmaceuticals LLC
$34
BioCryst US Sales Co., LLC
$32
Bayer Healthcare Pharmaceuticals Inc.
$30
Chiesi USA, Inc.
$26
Octapharma USA, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$24
Kyowa Kirin, Inc.
$24
Novartis Pharmaceuticals Corporation
$23
Circassia Inc.
$23
Pharming Healthcare, Inc.
$22
Nevro Corp.
$22
PFIZER INC.
$18
Tolmar, Inc.
$15
Top 3 companies account for 27.9% of 2024 payments
All-time payments by company (2018-2024) ›
SANOFI-AVENTIS U.S. LLC
$40,443
Novo Nordisk Inc
$40,311
AstraZeneca Pharmaceuticals LP
$1,235
Lilly USA, LLC
$1,042
Radius Health, Inc.
$649
GENZYME CORPORATION
$641
GlaxoSmithKline, LLC.
$466
Takeda Pharmaceuticals U.S.A., Inc.
$416
Abbott Laboratories
$396
Boehringer Ingelheim Pharmaceuticals, Inc.
$363
Amgen Inc.
$349
Dexcom, Inc.
$337
Mannkind Corporation
$318
CSL Behring
$278
Shire North American Group Inc
$250
Xeris Pharmaceuticals, Inc.
$250
IBSA Pharma Inc.
$235
Bayer HealthCare Pharmaceuticals Inc.
$228
MannKind Corporation
$217
Horizon Therapeutics plc
$184
Insulet Corporation
$179
Genentech USA, Inc.
$179
Tandem Diabetes Care, Inc.
$139
Corcept Therapeutics
$131
Regeneron Healthcare Solutions, Inc.
$125
EISAI INC.
$125
Alexion Pharmaceuticals, Inc.
$122
Antares Pharma, Inc.
$111
Almatica Pharma LLC
$111
Amneal Pharmaceuticals LLC
$93
Nevro Corp.
$84
Kyowa Kirin, Inc.
$78
BETA BIONICS, INC.
$71
Esperion Therapeutics, Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$60
Amryt Pharma Holdings Ltd
$50
RECORDATI_RARE_DISEASES_INC.
$45
ABBVIE INC.
$42
Pharming Healthcare, Inc.
$41
BioCryst US Sales Co., LLC
$32
Eisai Inc.
$31
Ultragenyx Pharmaceutical Inc.
$28
Chiesi USA, Inc.
$26
Medtronic, Inc.
$25
LifeScan, Inc.
$25
Currax Pharmaceuticals LLC
$24
Octapharma USA, Inc.
$24
Novartis Pharmaceuticals Corporation
$23
Ascensia Diabetes Care Us Inc.
$23
Circassia Inc.
$23
Merck Sharp & Dohme LLC
$22
VIVUS LLC
$21
Supernus Pharmaceuticals, Inc.
$20
Medtronic MiniMed, Inc.
$19
PFIZER INC.
$18
DEXCOM, INC.
$18
Merck Sharp & Dohme Corporation
$16
Tolmar, Inc.
$15
Top 3 companies account for 90.2% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AIRSUPRA · AREXVY · BAQSIMI · BASAGLAR · Belviq · CONTRAVE · CUVITRU · Crysvita · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DUPIXENT · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · FARXIGA · FASENRA · FORTEO · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HYQVIA · Haegarda · JANUVIA · JARDIANCE · JATENZO · Kcentra · Kerendia · Korlym · LEQVIO · LICART · LOKELMA · Lenvima · MOUNJARO · MYALEPT · MYCAPSSA · Minimed 670G System · NATPARA · NEXLETOL · NIOX · NOCDURNA · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ORLADEYO · Omnipod · OneTouch Verio Reflect · Ozempic · PRALUENT ALIROCUMAB INJECTION · QSYMIA · RECORLEV · RUCONEST · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STRENSIQ · SYNJARDY · SYNTHROID · Senza · TAKHZYRO · TEPEZZA · TERIPARATIDE · TEZSPIRE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tymlos · UNITHROID · Wegovy · XYOSTED · Xolair · Xultophy 100/3.6 · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an internal medicine specialist in Naples?
Compare internal medicine physicians in the Naples area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians in nearby ZIP areas
546
County median income
$86,173
Nearest hospital to ZIP centroid (approximate)
PHYSICIANS REGIONAL MEDICAL CENTER - PINE RIDGE
5.2 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment ✓ PECOS PECOS snapshot
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Neagu is a clinical cardiology specialist, with above-average Medicare volume (top 7% in FL), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Neagu experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Neagu performed 4,020 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Neagu receive payments from pharmaceutical companies?
Yes. Dr. Neagu received a total of $90,892 from 58 companies across 446 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neagu's costs compare to other internal medicine physicians in Naples?
Dr. Neagu's average Medicare payment per service is $33. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neagu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →